Roivant Sciences Ltd
For the period ended Mar 31, 2024. Filed May 30, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 30, 2024
ROIV$40.67+4.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| ITEM 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
|---|
| Roivant Sciences Ltd. Index to Consolidated Financial Statements | |
|---|---|
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 42) | 136 |
| Consolidated Financial Statements | |
| Consolidated Balance Sheets as of March 31, 2024 and 2023 | 140 |
| Consolidated Statements of Operations for the Years Ended March 31, 2024 and 2023 | 141 |
| Consolidated Statements of Comprehensive Income (Loss) for the Years Ended March 31, 2024 and 2023 | 142 |
| Consolidated Statements of Shareholders’ Equity and Redeemable Noncontrolling Interest for the Years Ended March 31, 2024 and 2023 | 143 |
| Consolidated Statements of Cash Flows for the Years Ended March 31, 2024 and 2023 | 144 |
| Notes to Consolidated Financial Statements | 145 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.